甲状腺球蛋白和甲状腺球蛋白抗体在分化型甲状腺癌诊治中的应用进展
程少浩， 苏艳军， 程若川 - 中国肿瘤临床, 2020 - cjco.cn
分化型甲状腺癌(differentiated thyroid cancer, DTC) 作为目前发病率上升最快,
甲状腺外科最常见的内分泌恶性肿瘤而备受关注. 通常选择甲状腺全切或近全切除术 …
甲状腺外科最常见的内分泌恶性肿瘤而备受关注. 通常选择甲状腺全切或近全切除术 …
Circulating MicroRNA profiles as potential biomarkers for differentiated thyroid cancer recurrence
J Jankovic Miljus, MA Guillén-Sacoto… - The Journal of …, 2022 - academic.oup.com
Abstract Context Circulating microRNAs (miRNAs) are emerging biomarkers of thyroid
cancer. Objective This study sought to identify the profile of circulating miRNAs and its …
cancer. Objective This study sought to identify the profile of circulating miRNAs and its …
甲状腺球蛋白抗体对甲状腺乳头状癌131I 清甲疗效的影响
张娜， 梁军， 林岩松 - 中国癌症杂志, 2017 - china-oncology.com
背景与目的: 甲状腺球蛋白抗体(thyroglobulin antibody, TgAb) 在甲状腺乳头状癌(papillary
thyroid carcinoma, PTC) 中较为常见. 该研究旨在探讨PTC 患者术后TgAb 对131 I …
thyroid carcinoma, PTC) 中较为常见. 该研究旨在探讨PTC 患者术后TgAb 对131 I …
Endocrine incidentalomas
LF Starker, PA Prieto, JS Liles… - Current problems …, 2016 - pubmed.ncbi.nlm.nih.gov
Endocrine incidentalomas Endocrine incidentalomas Curr Probl Surg. 2016 May;53(5):219-46.
doi: 10.1067/j.cpsurg.2016.04.001. Epub 2016 May 3. Authors Lee F Starker 1 , Peter A Prieto …
doi: 10.1067/j.cpsurg.2016.04.001. Epub 2016 May 3. Authors Lee F Starker 1 , Peter A Prieto …
Prognostic value of preoperative thyroid autoantibodies for post‐thyroidectomy patient pathology: A retrospective cohort study
SS Al‐Angari, HS AlAngari… - Clinical …, 2023 - Wiley Online Library
Objective The aim of this study was to evaluate the clinical value of preoperative thyroid
autoantibodies with reference to the post‐thyroidectomy patient pathology. Design A …
autoantibodies with reference to the post‐thyroidectomy patient pathology. Design A …
Mendelian randomization supports a causative effect of TSH on thyroid carcinoma
JM Fussey, RN Beaumont, AR Wood… - Endocrine-related …, 2020 - erc.bioscientifica.com
Evidence from observational studies suggests a positive association between serum thyroid
stimulating hormone (TSH) levels and differentiated thyroid carcinoma. However, the cause …
stimulating hormone (TSH) levels and differentiated thyroid carcinoma. However, the cause …
[HTML][HTML] Management approach to thyroid nodules
R Arrangoiz, F Cordera, D Caba, E Moreno… - International Journal of …, 2018 - scirp.org
Thyroid nodules are a major health problem worldwide. The prevalence of palpable thyroid
nodules in the general population is approximately 5% in women and 1% in men living in …
nodules in the general population is approximately 5% in women and 1% in men living in …
[PDF][PDF] Hashimoto's Thyroiditis and thyroid cancer
JMG Sáez - J. Hum. Endocrinol, 2016 - pdfs.semanticscholar.org
The association between Hashimoto's thyroiditis and thyroid follicular epithelium cancer,
such as papillary carcinoma, remains unclear. The evidence, from several countries, is that …
such as papillary carcinoma, remains unclear. The evidence, from several countries, is that …
Vascular endothelial growth factor G+ 405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma
İ Bingül, P Vural, S Doğru‐Abbasoğlu… - Journal of Clinical …, 2017 - Wiley Online Library
Background Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy.
Vascular endothelial growth factor (VEGF) is a mediator implicated with cell proliferation …
Vascular endothelial growth factor (VEGF) is a mediator implicated with cell proliferation …
[HTML][HTML] Современные прогностические модели стратификации риска рака щитовидной железы
СВ Новосад, МО Рогова, НС Мартиросян… - Доктор. Ру, 2016 - cyberleninka.ru
Узловые образования щитовидной железы (ЩЖ) признаны самым распространенным
эндокринным заболеванием. Доля злокачественных новообразований среди них …
эндокринным заболеванием. Доля злокачественных новообразований среди них …